OBJECTIVE: To report the use of dexmedetomidine to facilitate rapid opioid and benzodiazepine withdrawal in children with transplanted hearts and to review the receptor physiology and pharmacodynamic impact of dexmedetomidine on the denervated heart. DESIGN: Case series. SETTING: Intensive care unit at a tertiary pediatric medical center. PATIENTS: The series included a 6-month-old infant with pulmonary atresia who had a 3-month exposure to high-dose opioids and benzodiazepines and had undergone cardiac transplantation 4 wks before the use of dexmedetomidine and a 7-yr-old boy who had been sedated while undergoing extracorporeal membrane oxygenation for 3 wks before transplantation and started to receive dexmedetomidine 3 days after transplantation. INTERVENTION: Administration of dexmedetomidine to facilitate the discontinuation of opioids and benzodiazepine. MAIN RESULT: Successful rapid withdrawal from opioids and benzodiazepines while maintaining hemodynamic stability. CONCLUSION: To our knowledge, this report describes the first use of dexmedetomidine to facilitate opioid withdrawal in children with a cardiac transplant. Dexmedetomidine allowed for the preservation of satisfactory hemodynamic parameters during acute withdrawal from opioids in children with denervated hearts.
OBJECTIVE: To report the use of dexmedetomidine to facilitate rapid opioid and benzodiazepine withdrawal in children with transplanted hearts and to review the receptor physiology and pharmacodynamic impact of dexmedetomidine on the denervated heart. DESIGN: Case series. SETTING: Intensive care unit at a tertiary pediatric medical center. PATIENTS: The series included a 6-month-old infant with pulmonary atresia who had a 3-month exposure to high-dose opioids and benzodiazepines and had undergone cardiac transplantation 4 wks before the use of dexmedetomidine and a 7-yr-old boy who had been sedated while undergoing extracorporeal membrane oxygenation for 3 wks before transplantation and started to receive dexmedetomidine 3 days after transplantation. INTERVENTION: Administration of dexmedetomidine to facilitate the discontinuation of opioids and benzodiazepine. MAIN RESULT: Successful rapid withdrawal from opioids and benzodiazepines while maintaining hemodynamic stability. CONCLUSION: To our knowledge, this report describes the first use of dexmedetomidine to facilitate opioid withdrawal in children with a cardiac transplant. Dexmedetomidine allowed for the preservation of satisfactory hemodynamic parameters during acute withdrawal from opioids in children with denervated hearts.
Authors: Kathy A Sheehy; Julia C Finkel; Deepika S Darbari; Michael F Guerrera; Zenaide M N Quezado Journal: Pain Pract Date: 2015-07-23 Impact factor: 3.183
Authors: Mary Jo C Grant; James B Schneider; Lisa A Asaro; Brenda L Dodson; Brent A Hall; Shari L Simone; Allison S Cowl; Michele M Munkwitz; David Wypij; Martha A Q Curley Journal: Pediatr Crit Care Med Date: 2016-12 Impact factor: 3.624
Authors: Kanwaljeet J S Anand; Douglas F Willson; John Berger; Rick Harrison; Kathleen L Meert; Jerry Zimmerman; Joseph Carcillo; Christopher J L Newth; Parthak Prodhan; J Michael Dean; Carol Nicholson Journal: Pediatrics Date: 2010-04-19 Impact factor: 7.124
Authors: Cristina Lopez-Peig; Xavier Mundet; Bartomeu Casabella; Jose Luis del Val; David Lacasta; Eduard Diogene Journal: BMC Res Notes Date: 2012-12-13